Case number 1:21-cv-02899
AbbVie Inc. et al v. Alvotech hf. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 3, 2022 | 140 | response in opposition to motion (4) Docket Text: RESPONSE by AbbVie Biotechnology Ltd, AbbVie Inc. in Opposition to MOTION by Defendant Alvotech hf. to dismiss / Defendant Alvotech hf.'s Renewed Rule 12(B)(1), 12(B)(2), 12(B)(6), and 12(B)(7) Motion to Dismiss for Lack of Subject Matter Jurisdiction, Lack of Personal Jurisdiction, Failure to State a Claim, an[138] (Morin, Michael) 141 Filed & Entered: 01/05/2022 set/reset hearings Docket Text: MINUTE entry before the Honorable John Z. Lee: The claim construction hearing is set for 1/13/22 at 10:30 a.m. Counsel will receive a webex invitation by email. The pretrial conference is set for 7/25/22 at 10:00 a.m. Per the scheduling order: Plaintiffs' List of Asserted Claims (LPR 3.1(a)(1)) due 1/14/2022 ;Plaintiffs' Final Infringement Contentions (LPR 3.1(a)(2)) due 1/28/2022 ; Defendant's Final Unenforceability and Invalidity Contentions (LPR 3.1(b), 3.3) due 1/28/2022 ;Defendant's Final Non-Infringement Contentions (LPR 3.2(a)) due 2/18/2022; Plaintiffs' Final Enforceability and Validity Contentions (LPR 3.2(b)) due 2/18/2022; Fact Discovery Closes (LPR 1.3) due 3/2/2022;Opening Expert Reports by burden of proof (including arguments on secondary considerations by both parties) due 3/17/2022;Rebuttal Expert Reports (including responses to secondary considerations by both parties) (LPR 5.1(c)) due 4/27/2022; Expert Discovery Closes (LPR 5.2) due 6/14/2022; Serve Pretrial Disclosures;File MotionsinLimine 6/28/2022; Serve Objections to Pretrial Disclosures; Serve Rebuttal Pretrial Disclosures 7/11/2022; Serve Objections to Rebuttal Pretrial Disclosures 7/18/2022 ;File Joint Pretrial Order, Responses to MotionsinLimine, Updated Exhibit Lists, Updated Witness Lists, and Updated Deposition Designations by 7/18/2022. (ca, ) 142 Filed & Entered: 01/05/2022Terminated: 01/10/2022 motion for leave to file Docket Text: MOTION by Defendant Alvotech hf. for leave to file / Defendant Alvotech hf.'s Motion for Leave to File Under Seal Portions of Alvotech hf.'s Answer to Plaintiffs' Second Amended Complaint and Counterclaims and Certain Exhibits to the Same (Fogel, Louis) 143 Filed & Entered: 01/05/2022 sealed document Docket Text: SEALED DOCUMENT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Answer to Plaintiffs' Second Amended Complaint and Counterclaims (Attachments: # (1) Exhibit A, # (2) Exhibit D)(Fogel, Louis) 144 Filed & Entered: 01/05/2022 answer to amended complaint Docket Text: ANSWER to amended complaint / Defendant Alvotech hf.'s Answer to Plaintiffs' Second Amended Complaint and Counterclaims by Alvotech hf. (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D - Filed Under Seal, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I)(Fogel, Louis) 145 Filed & Entered: 01/06/2022 text entry Docket Text: MINUTE entry before the Honorable John Z. Lee: The telephone number for the public for the claim construction hearing scheduled for 1/13/22 at 10:30 a.m. is: 1-650-479-3207; Access code: 2305 766 1212. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, ) 146 Filed & Entered: 01/06/2022 notification of affiliates pursuant to local rule 3.2 Docket Text: NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by AbbVie Biotechnology Ltd (Supplemental) (Berkowitz, Sean) 147 Filed & Entered: 01/07/2022 other Docket Text: Plaintiffs' Notice of Narrowing of Claim Construction Issues by AbbVie Biotechnology Ltd, AbbVie Inc. (Morin, Michael) 148 Filed & Entered: 01/07/2022 notice of filing Docket Text: NOTICE by Alvotech hf. re reply, [126] / Notice of Filing of Corrected Version of Exhibit 24 to Declaration of Louis E. Fogel (Fogel, Louis) 149 Filed & Entered: 01/07/2022 exhibit Docket Text: SEALED EXHIBIT by Defendant Alvotech hf. / Corrected Exhibit 24 to Declaration of Louis E. Fogel regarding notice of filing[148], reply, [126] (Fogel, Louis) 150 Filed & Entered: 01/07/2022Terminated: 01/14/2022 motion for leave to file Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for leave to file under seal (Morin, Michael) 151 Filed & Entered: 01/07/2022 status report Docket Text: STATUS Report (Joint) by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 1)(Morin, Michael) 152 Filed & Entered: 01/07/2022 sealed document Docket Text: SEALED DOCUMENT by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. - Joint Status Report (Attachments: # (1) Exhibit 1)(Morin, Michael) 153 Filed & Entered: 01/10/2022 terminate hearings Docket Text: MINUTE entry before the Honorable John Z. Lee:Due to scheduling issues, the Markman hearing currently scheduled for 1/13/22 is stricken and will need to be rescheduled. Counsel for both parties are directed to meet and confer and provide the courtroom deputy by 1/12/22 with three alternative dates for the hearing during the weeks of 1/18/22 and 1/24/22. (ca, ) 154 Filed & Entered: 01/10/2022 order on motion for leave to file Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for leave to file under seal portions of Alvotech hf.'s Answer to Plaintiffs' Second Amended Complaint and Counterclaims and Certain Exhibits [142] is granted. (ca, ) 155 Filed & Entered: 01/11/2022Terminated: 01/12/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19043556. (Behrendt, Benjamin) 156 Filed & Entered: 01/11/2022 attorney appearance Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by Roger Alen Denning (Denning, Roger) 157 Filed & Entered: 01/12/2022 order on motion to appear pro hac vice Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion to appear pro hac vice by Benjamin Behrendt [155] is granted. (ca, ) 158 Filed & Entered: 01/12/2022Terminated: 01/14/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19049097. (Biegler, Geoff) 159 Filed & Entered: 01/12/2022Terminated: 01/14/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19049632. (Denning, Roger) 160 Filed & Entered: 01/12/2022Terminated: 01/14/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19050010. (Williams, Kelly) 161 Filed & Entered: 01/12/2022Terminated: 01/14/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19051210. (Bandyopadhyay, Esha) 162 Filed & Entered: 01/12/2022Terminated: 01/13/2022 motion to expedite Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to expedite - Plaintiffs' Motion for Expedited Briefing Schedule (Morin, Michael) 163 Filed & Entered: 01/12/2022Terminated: 01/13/2022 motion for leave to file Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for leave to file under seal (Morin, Michael) 164 Filed & Entered: 01/12/2022Terminated: 01/26/2022 motion to compel Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to compel - Plaintiffs' Motion to Compel Third-Party Teva Pharmaceuticals USA, Inc. to Produce Documents and Things in Response to Subpoena (Attachments: # (1) Declaration of Will Orlady, # (2) Index of Exhibits, # (3) Exhibit 1, # (4) Exhibit 2 - Filed Under Seal, # (5) Exhibit 3, # (6) Exhibit 4, # (7) Exhibit 5 - Filed Under Seal, # (8) Exhibit 6 - Filed Under Seal, # (9) Exhibit 7 - Filed Under Seal, # (10) Exhibit 8 - Filed Under Seal, # (11) Exhibit 9, # (12) Exhibit 10, # (13) Exhibit 11, # (14) Exhibit 12, # (15) Exhibit 13 - Filed Under Seal, # (16) Exhibit 14 - Filed Under Seal, # (17) Exhibit 15 - Filed Under Seal, # (18) Exhibit 16 - Filed Under Seal, # (19) Exhibit 17 - Filed Under Seal, # (20) Exhibit 18 - Filed Under Seal, # (21) Exhibit 19 - Filed Under Seal, # (22) Exhibit 20 - Filed Under Seal, # (23) Exhibit 21 - Filed Under Seal, # (24) Exhibit 22 - Filed Under Seal, # (25) Exhibit 23 - Filed Under Seal, # (26) Exhibit 24 - Filed Under Seal)(Morin, Michael) 165 Filed & Entered: 01/12/2022Terminated: 01/26/2022 Sealed motion Docket Text: SEALED MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. - Plaintiffs' Motion to Compel Third-Party Teva Pharmaceuticals USA, Inc. to Produce Documents and Things in Response to Subpoena (Attachments: # (1) Declaration of Will Orlady, # (2) Index of Exhibits, # (3) Exhibit 2, # (4) Exhibit 5, # (5) Exhibit 6, # (6) Exhibit 7, # (7) Exhibit 8, # (8) Exhibit 13, # (9) Exhibit 14, # (10) Exhibit 15, # (11) Exhibit 16, # (12) Exhibit 17, # (13) Exhibit 18, # (14) Exhibit 19, # (15) Exhibit 20, # (16) Exhibit 21, # (17) Exhibit 22, # (18) Exhibit 23, # (19) Exhibit 24)(Morin, Michael) 166 Filed & Entered: 01/13/2022Terminated: 01/14/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19052183. (Shmuel, Jenny) 167 Filed & Entered: 01/13/2022 order on motion for leave to file Docket Text: MINUTE entry before the Honorable M. David Weisman: Plaintiff's motion for leave to file under seal [163] is granted. Plaintiff shall file a redacted version of the motion and confidential documents on the docket. Mailed notice (ao, ) 168 Filed & Entered: 01/13/2022 order on motion to expedite Docket Text: MINUTE entry before the Honorable M. David Weisman: Plaintiffs' motion for expedited briefing schedule [162] is granted. Subpoena respondent shall respond by 1/24/22: No reply unless requested by the court. Status hearing set for 1/24/22 stands. Mailed notice (ao, ) (Docket Text Modified by Chambers Staff.) 169 Filed & Entered: 01/13/2022Terminated: 01/14/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19054373. (Farrell, John) 170 Filed & Entered: 01/13/2022Terminated: 03/09/2022 motion to seal Docket Text: MOTION by Defendant Alvotech hf. to seal / Defendant Alvotech hf.'s Motion for Leave to File Under Seal Exhibits to Declaration of Louis E. Fogel in Support of Alvotech hf.'s Response to Plaintiffs' Notice of Narrowing of Claim Construction Issues and Notice of Supplemental Tutorial Exhibits (Fogel, Louis) 171 Filed & Entered: 01/13/2022 Response Docket Text: RESPONSE by Defendant Alvotech hf. to other[147] / Defendant Alvotech hf.'s Response to Plaintiffs' Notice of Narrowing of Claim Construction Issues and Notice of Supplemental Tutorial Exhibits (Attachments: # (1) Declaration of Louis E. Fogel, # (2) Exhibit 1 - To be Filed Under Seal, # (3) Exhibit 2 - To be Filed Under Seal)(Fogel, Louis) 172 Filed & Entered: 01/13/2022 exhibit Docket Text: SEALED EXHIBIT by Defendant Alvotech hf. / Exhibit 1 regarding Response, [171] (Attachments: # (1) Exhibit 2)(Fogel, Louis) 173 Filed & Entered: 01/14/2022 set deadlines/hearings Docket Text: MINUTE entry before the Honorable John Z. Lee: The claim construction hearing is set for 1/26/22 at 10:30 a.m. (ca, ) 174 Filed & Entered: 01/14/2022 text entry Docket Text: MINUTE entry before the Honorable John Z. Lee:Plaintiff's reply to Defendant's Response to Plaintiffs' Notice of Narrowing of Claim Construction Issues and Notice of Supplemental Tutorial Exhibits [171] is due 1/19/22. (ca, ) 175 Filed & Entered: 01/14/2022 order on motion to appear pro hac vice Docket Text: MINUTE entry before the Honorable John Z. Lee:Motions to appear pro hac vice [158] [159] [160] [161] [166] [169] are granted. (ca, ) 176 Filed & Entered: 01/14/2022 order on motion for leave to file Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for leave to file under seal [150] is granted. (ca, ) 177 Filed & Entered: 01/18/2022Terminated: 01/25/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19064312. (Rocetti, Jennifer) 178 Filed & Entered: 01/18/2022Terminated: 01/25/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19064399. (Dippold, Rachael) 179 Filed & Entered: 01/18/2022Terminated: 01/25/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19064463. (Yang, Yieyie) 180 Filed & Entered: 01/18/2022 attorney appearance Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by Geoff D Biegler (Biegler, Geoff) 181 Filed & Entered: 01/18/2022 attorney appearance Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by John M. Farrell (Farrell, John) 182 Filed & Entered: 01/19/2022 terminate motion and R&R deadlines/hearings Docket Text: MINUTE entry before the Honorable M. David Weisman: Minute Entry [168] is amended as follows: Subpoena respondent's response is due by noon 1/21/22. Status hearing set for 1/24/22 stands. Mailed notice (ao, ) 183 Filed & Entered: 01/19/2022 attorney appearance Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by Jenny Shmuel (Shmuel, Jenny) 184 Filed & Entered: 01/19/2022Terminated: 01/25/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19070286. (Orlady, Will) 185 Filed & Entered: 01/19/2022Terminated: 01/25/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19070356. (Sun, Yi) 186 Filed & Entered: 01/19/2022Terminated: 01/25/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19070427. (Hoxha, Eneda) 187 Filed & Entered: 01/19/2022 reply Docket Text: REPLY by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to Response, [171] - Plaintiffs' Reply to Defendant's Response to Plaintiffs' Notice of Narrowing of Claim Construction Issues (Berkowitz, Sean) 188 Filed & Entered: 01/20/2022 attorney appearance Docket Text: ATTORNEY Appearance for Respondent Teva Pharmaceuticals, USA Inc. by James J. Lukas, Jr (Lukas, James) 189 Filed & Entered: 01/21/2022Terminated: 01/25/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19077378. (Bornstein, Scott) 190 Filed & Entered: 01/21/2022Terminated: 01/21/2022 motion to seal Docket Text: MOTION by Respondent Teva Pharmaceuticals, USA Inc. to seal (Lukas, James) 191 Filed & Entered: 01/21/2022 declaration Docket Text: DECLARATION of Giancarlo L. Scaccia in Support of Opposition to Plaintiffs' Motion to Compel (Attachments: # (1) Exhibit A, # (2) Exhibit N)(Lukas, James) 192 Filed & Entered: 01/21/2022 response in opposition to motion Docket Text: RESPONSE by Teva Pharmaceuticals, USA Inc.in Opposition to MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to compel - Plaintiffs' Motion to Compel Third-Party Teva Pharmaceuticals USA, Inc. to Produce Documents and Things in Response to Subpoena[164] (Lukas, James) 193 Filed & Entered: 01/21/2022 order on motion to seal Docket Text: MINUTE entry before the Honorable M. David Weisman: Non-Party Teva Pharmaceuticals, USA motion for leave to file under seal portions of Teva's opposition to plaintiffs' motion to compel and certain exhibits to the declaration of Giancarlo L. Scaccia [190] is granted. Mailed notice (ao, ) 194 Filed & Entered: 01/21/2022 sealed response Docket Text: SEALED RESPONSE by Teva Pharmaceuticals, USA Inc. to MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to compel - Plaintiffs' Motion to Compel Third-Party Teva Pharmaceuticals USA, Inc. to Produce Documents and Things in Response to Subpoena[164] (Lukas, James) 195 Filed & Entered: 01/21/2022 exhibit Docket Text: SEALED EXHIBIT by Respondent Teva Pharmaceuticals, USA Inc. regarding declaration[191] (Attachments: # (1) Exhibit B, # (2) Exhibit C, # (3) Exhibit D, # (4) Exhibit E, # (5) Exhibit F, # (6) Exhibit G, # (7) Exhibit H, # (8) Exhibit I, # (9) Exhibit J, # (10) Exhibit K, # (11) Exhibit L, # (12) Exhibit M, # (13) Exhibit N)(Lukas, James) 196 Filed & Entered: 01/21/2022Terminated: 01/25/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19079732. (Zhang, Linhong) 197 Filed & Entered: 01/21/2022 terminate hearings Docket Text: MINUTE entry before the Honorable M. David Weisman: Having reviewed the parties' submissions, the Court does not believe oral argument is necessary on plaintiffs' motion to compel [164]. Accordingly, the Court strikes the 1/24/22 hearing and will issue a decision as soon as reasonably possible. Mailed notice (ao, ) 198 Filed & Entered: 01/24/2022 set/reset hearings Docket Text: MINUTE entry before the Honorable John Z. Lee: Telephone status hearing is set for 1/24/22 at 2:00 p.m.The telephone number for the public is 888-273-3658 and the access code is 1637578. Counsel of record will receive a separate email at least 12 hours prior to the start of the telephonic hearing with instructions on how to join the call. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, ) 199 Filed & Entered: 01/24/2022Terminated: 01/24/2022 motion to seal Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to seal the Courtroom for a Portion of the Technology Tutorial and Hearing on Claim Construction (Joint) (Morin, Michael) 200 Filed & Entered: 01/24/2022 order on motion to seal Docket Text: MINUTE entry before the Honorable John Z. Lee: Status hearing held on 1/24/22. The Markman hearing set for 1/26/22 is reset to 2/4/22 at 8:30 a.m. in person. Plaintiffs' Final Infringement Contentions (LPR 3.1(a)(2)) and Defendant's Final Unenforceability and Invalidity Contentions (LPR 3.1(b), 3.3) are stayed until the 2/4/22 hearing. Joint motion to seal the courtroom for a portion of the technology tutorial and hearing [199] is granted. The Court will issue an agenda prior to the hearing. (ca, ) 201 Filed & Entered: 01/24/2022Terminated: 01/25/2022 motion for miscellaneous relief Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for Additional Pages and to Incorporate Prior Briefing by Reference (Unopposed) (Morin, Michael) 202 Filed & Entered: 01/25/2022 order on motion to appear pro hac vice Docket Text: MINUTE entry before the Honorable John Z. Lee:Motions to appear pro hac vice by Jennifer Rocetti [177], Rachael Dippold [178] Yieyie Yang [179], Will Orlady [184], Yi Sun [185], Eneda Hoxha [186], Scott Bornstein [189] and Linhonh Zhang [196] are granted. (ca, ) 203 Filed & Entered: 01/25/2022 order on motion for miscellaneous relief Docket Text: MINUTE entry before the Honorable John Z. Lee:As to Plaintiff's motion [201]: In order to maintain the clarity of the record in this action, any and all arguments by AbbVie to support its motion to dismiss Alvotech's counterclaims should be set forth in one brief, filed in this case. Therefore, the motion to incorporate by reference is denied. However, the Court will grant AbbVie up to 22 pages to set forth all of its arguments in support of its motion to dismiss. Alvotech's response will be limited to 22 pages, as well. Abbvie's reply will be limited to 15 pages. (ca, ) 204 Filed & Entered: 01/26/2022 attorney appearance Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by Linhong Zhang (Zhang, Linhong) 205 Filed & Entered: 01/26/2022Terminated: 01/27/2022 motion for extension of time to file Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for extension of time to file Motion to Strike and Dismiss (Unopposed) (Morin, Michael) 206 Filed & Entered: 01/26/2022 order on motion to compel Docket Text: SEALED ORDER: Signed by the Honorable M. David Weisman on 1/26/2022. Mailed notice (ao, ) 207 Filed & Entered: 01/26/2022 text entry Docket Text: MINUTE entry before the Honorable M. David Weisman: Out of an abundance of caution, the Court has placed under seal its order resolving Abbvie's motion to compel Teva to produce documents (See docket entry no. [206]). The parties have until COB 1/28/22 to review the order and tell the Court, via a statement submitted to the Court's proposed order in box, whether the seal is necessary. If any party believes the seal should be maintained, they should submit a copy of the Court's order with the confidential information highlighted. After reviewing the submissions, the Court will determine whether the Order will remain sealed in whole or part. Mailed notice (ao, ) 208 Filed & Entered: 01/26/2022 order on motion to dismiss Docket Text: MINUTE entry before the Honorable John Z. Lee: For the reasons stated in the memorandum opinion and order, Alvotech hf.'s motion to dismiss [28] is denied in its entirety. [For further details see memorandum opinion and order]. Mailed notice (mjc, ) 209 Filed & Entered: 01/26/2022 memorandum opinion and order Docket Text: MEMORANDUM Opinion and Order Signed by the Honorable John Z. Lee on 1/26/2022. Mailed notice(mjc, ) 211 Filed: 01/26/2022 Entered: 01/31/2022 order Docket Text: ORDER: For the reasons set forth in this order, the Court grants in part and denies in part the motion [178 & 179 2258 case & [164] & [165] 2899 case]. Teva is ordered to supplement its production and submit the declaration as set forth in this Order by February 11, 2022. (For further details see order.) Signed by the Honorable M. David Weisman on 1/26/2022. Mailed notice (ao, ) 210 Filed & Entered: 01/27/2022 order on motion for extension of time to file Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for extension of time to file motion to strike and dismiss [205] is granted. Motion to strike and dismiss is due by 1/31/22. (ca, ) 212 Filed & Entered: 01/31/2022 stipulation Docket Text: STIPULATION and [Proposed] Order Regarding Remote Depositions (Danek, Brenda) 213 Filed & Entered: 01/31/2022Terminated: 03/09/2022 motion for leave to file Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for leave to file under seal (Morin, Michael) 214 Filed & Entered: 01/31/2022Terminated: 03/09/2022 motion to dismiss Docket Text: MOTION by Plaintiffs AbbVie Inc., AbbVie Biotechnology Ltd to dismiss and Strike Defendant's Counterclaims and Affirmative Defenses of Inequitable Conduct, Unclean Hands, and Patent Misuse (Morin, Michael) 215 Filed & Entered: 01/31/2022 memorandum in support of motion Docket Text: MEMORANDUM by AbbVie Biotechnology Ltd, AbbVie Inc. in support of motion to dismiss[214] and Strike Defendant's Counterclaims and Affirmative Defenses of Inequitable Conduct, Unclean Hands, and Patent Misuse (Morin, Michael) 216 Filed & Entered: 01/31/2022 declaration Docket Text: DECLARATION of Herman Yue regarding motion to dismiss[214] and Strike Defendant's Counterclaims and Affirmative Defenses of Inequitable Conduct, Unclean Hands, and Patent Misuse (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1 - Filed Under Seal, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5)(Morin, Michael) 217 Filed & Entered: 01/31/2022 exhibit Docket Text: SEALED EXHIBIT by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. - Sealed Exhibit 1 regarding declaration, [216] (Morin, Michael) 218 Filed & Entered: 02/02/2022 order Docket Text: MARKMAN Hearing Agenda Signed by the Honorable John Z. Lee on 2/2/22.(ca, ) 219 Filed & Entered: 02/02/2022Terminated: 02/07/2022 motion for extension of time to file Docket Text: MOTION by Respondent Teva Pharmaceuticals, USA Inc. for extension of time to file - Motion for Clarification and for Extension of Time (Attachments: # (1) Exhibit A)(Lukas, James) 220 Filed & Entered: 02/03/2022 set motion and R&R deadlines/hearings Docket Text: MINUTE entry before the Honorable M. David Weisman: Respondent Teva Pharmaceuticals USA, Inc's motion for clarifications and for an extension of time [219] is entered and briefed as follows: Plaintiff's shall respond by 2/14/22; No reply. Motion hearing set for 2/23/22 at 9:15 a.m. Parties shall dial in using the Court's conference call-in number. The conference call-in number is 1-877-411-9748 and the passcode is 1814539. Mailed notice (ao, ) 221 Filed & Entered: 02/03/2022Terminated: 02/04/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19119570. (Tzeng, Linfong) 222 Filed & Entered: 02/03/2022 stipulation and order Docket Text: STIPULATION AND ORDER REGARDING REMOTE DEPOSITIONS AND DEPOSITIONS OF WITNESSES LOCATED IN GERMANY AND ICELAND: Signed by the Honorable M. David Weisman on 2/3/2022. Mailed notice (ao, ) 223 Filed & Entered: 02/03/2022 set/reset hearings Docket Text: MINUTE entry before the Honorable M. David Weisman: The Court set a status hearing in conjunction with the motion hearing that is currently set for 2/23/22 at 9:15 a.m. Parties shall file a joint status report on 2/21/22. Parties shall dial in using the Court's conference call-in number. The conference call-in number is 1-877-411-9748 and the passcode is 1814539. Mailed notice (ao, ) 224 Filed & Entered: 02/03/2022Terminated: 02/04/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19121414. (Kane, Michael) 225 Filed & Entered: 02/03/2022Terminated: 02/09/2022 motion for leave to file Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for leave to file under seal (Morin, Michael) 226 Filed & Entered: 02/03/2022 notice of filing Docket Text: NOTICE by AbbVie Biotechnology Ltd, AbbVie Inc. - Notice of Supplemental Exhibit (Attachments: # (1) Exhibit 1 - Filed Under Seal)(Morin, Michael) 227 Filed & Entered: 02/03/2022 exhibit Docket Text: SEALED EXHIBIT by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. - Sealed Exhibit 1 regarding notice of filing[226] (Morin, Michael) 228 Filed & Entered: 02/04/2022 order on motion to appear pro hac vice Docket Text: MINUTE entry before the Honorable John Z. Lee: Motions to appear pro hac vice by Linfong Tzeng and Michael Kane [221] [224] are granted. (ca, ) 229 Filed & Entered: 02/04/2022Terminated: 02/07/2022 motion for leave to file Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for leave to file under seal (Morin, Michael) 230 Filed & Entered: 02/04/2022Terminated: 02/07/2022 motion to expedite Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to expedite Consideration of Third-Party Teva Pharmaceuticals USA, Inc.'s Motion for Clarification and for an Extension of Time (Morin, Michael) 231 Filed & Entered: 02/04/2022 response in opposition to motion Docket Text: RESPONSE by AbbVie Biotechnology Ltd, AbbVie Inc. in Opposition to MOTION by Respondent Teva Pharmaceuticals, USA Inc. for extension of time to file - Motion for Clarification and for Extension of Time[219] (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1, # (3) Exhibit 2 - Filed Under Seal, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5 - Filed Under Seal)(Morin, Michael) 232 Filed & Entered: 02/04/2022 sealed response Docket Text: SEALED RESPONSE by AbbVie Biotechnology Ltd, AbbVie Inc. to response in opposition to motion, [231] (Attachments: # (1) Index of Exhibits, # (2) Exhibit 2 - Filed Under Seal, # (3) Exhibit 5 - Filed Under Seal)(Morin, Michael) 233 Filed & Entered: 02/04/2022 in court hearing Docket Text: MINUTE entry before the Honorable John Z. Lee: Markman hearing held on 2/4/22. As noted on the record, the Court continues the Markman hearing so that the Court can hear from the various experts on the issues discussed. The parties should meet and confer and email the Courtroom Deputy by 2/11/22 with potential dates for the hearing(s) and indicate whether they agree to have the hearings conducted via video conference. (ca, ) 234 Filed & Entered: 02/07/2022 order on motion for leave to file Docket Text: MINUTE entry before the Honorable M. David Weisman: Plaintiff's motion for leave to file under seal [229] is granted. Mailed notice (ao, ) 235 Filed & Entered: 02/07/2022 order on motion for extension of time to file Docket Text: MINUTE entry before the Honorable M. David Weisman: The Court grants in part Teva's motion for clarification [ECF [219]] and clarifies that the January 26, 2022 Order [ECF [211]] applies to Teva Pharmaceuticals, USA Inc. The motion is otherwise denied. Moreover, given the rapidly approaching discovery deadline, Teva's request for an extension of time to comply with the Court's Order is denied. Abbvie's motion to expedite [ECF [230]] is stricken as moot. Mailed notice (ao, ) 236 Filed & Entered: 02/08/2022 transcript Docket Text: TRANSCRIPT OF PROCEEDINGS held on 2/4/22 before the Honorable John Z. Lee. Court Reporter Contact Information: Joseph Rickhoff, 312-435-5562, joseph_rickhoff@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 3/1/2022. Redacted Transcript Deadline set for 3/11/2022. Release of Transcript Restriction set for 5/9/2022. (Rickhoff, Joseph) 237 Filed & Entered: 02/09/2022 order on motion for leave to file Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for leave to file under seal [225] is granted. (ca, ) 238 Filed & Entered: 02/14/2022 set/reset hearings Docket Text: MINUTE entry before the Honorable John Z. Lee:Claim construction hearing set for 3/23/22 at 10:00 a.m. in person. (ca, ) 239 Filed & Entered: 02/18/2022Terminated: 03/09/2022 motion for leave to file Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for leave to file under seal unredacted portions of Plaintiffs' Motion to Strike Defendant's Final Invalidity and Unenforceability Contentions ("Plaintiffs' Motion") and Exhibits 1-10, 12-14, and 16-20 to Plaintiffs' Motion (Morin, Michael) 240 Filed & Entered: 02/18/2022Terminated: 03/09/2022 motion to expedite Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to expedite briefing schedule and to Continue the due date for Plaintiffs' Responsive Final Contentions (Morin, Michael) 241 Filed & Entered: 02/18/2022Terminated: 03/09/2022 motion to strike Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to strike Defendant's Final Invalidity and Uneforceability Contentions (Morin, Michael) 242 Filed & Entered: 02/18/2022 memorandum in support of motion Docket Text: MEMORANDUM by AbbVie Biotechnology Ltd, AbbVie Inc. in support of motion to strike[241] (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6, # (8) Exhibit 7, # (9) Exhibit 8, # (10) Exhibit 9, # (11) Exhibit 10, # (12) Exhibit 11, # (13) Exhibit 12, # (14) Exhibit 13, # (15) Exhibit 14, # (16) Exhibit 15, # (17) Exhibit 16, # (18) Exhibit 17, # (19) Exhibit 18, # (20) Exhibit 19, # (21) Exhibit 20, # (22) Exhibit 21, # (23) Exhibit 22, # (24) Exhibit 23, # (25) Exhibit 24, # (26) Exhibit 25, # (27) Exhibit 26, # (28) Exhibit 27, # (29) Exhibit 28, # (30) Exhibit 29, # (31) Exhibit 30, # (32) Exhibit 31, # (33) Exhibit 32, # (34) Exhibit 33)(Morin, Michael) 243 Filed & Entered: 02/18/2022 sealed document Docket Text: SEALED DOCUMENT by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. Plaintiffs' Memorandum in Support of their Motion to Strike Defendant's Invalidity and Unenforceability Contentions (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 12, # (12) Exhibit 13, # (13) Exhibit 14, # (14) Exhibit 16, # (15) Exhibit 17, # (16) Exhibit 18, # (17) Exhibit 19, # (18) Exhibit 20)(Morin, Michael) 244 Filed & Entered: 02/21/2022Terminated: 03/09/2022 motion to seal Docket Text: MOTION by Defendant Alvotech hf. to seal Portions of Alvotech hf.'s First Amended Answer to Plaintiffs' Second Amended Complaint and Counterclaims and Certain Exhibits to the Same (Fogel, Louis) 245 Filed & Entered: 02/21/2022 answer to complaint Docket Text: First Amended ANSWER to Complaint with Jury Demand regarding Second Amended Complaint [130], COUNTERCLAIM filed by Alvotech hf. against AbbVie Biotechnology Ltd, AbbVie Inc. . by Alvotech hf. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N)(Fogel, Louis) 246 Filed & Entered: 02/21/2022 sealed document Docket Text: SEALED DOCUMENT by Defendant Alvotech hf. / Defendant Alvotech hf.'s First Amended Answer to Plaintiffs' Second Amended Complaint and Counterclaims [130] (Attachments: # (1) Exhibit A, # (2) Exhibit D)(Fogel, Louis) 247 Filed & Entered: 02/21/2022 status report Docket Text: STATUS Report (Joint) by AbbVie Biotechnology Ltd, AbbVie Inc. (Morin, Michael) 248 Filed & Entered: 02/23/2022 terminate motion and R&R deadlines/hearings Docket Text: MINUTE entry before the Honorable M. David Weisman: In light of the issues raised in the parties' Joint Status Report, and the impact these various scheduling issues may have on the overall case management schedule, the status hearing set for 2/23/22 is stricken to allow consultation and coordination with the district court. Status hearing set for 3/4/22 at 10:30 a.m. Parties shall dial in using the Court's conference call-in number. The conference call-in number is 1-877-411-9748 and the passcode is 1814539. Mailed notice (ao, ) 249 Filed & Entered: 02/25/2022Terminated: 03/09/2022 motion to seal Docket Text: MOTION by Defendant Alvotech hf. to seal / Defendant Alvotech hf.'s Motion for Leave to File Under Seal Portions of Alvotech hf.'s Opposition to Plaintiffs' Motion to Strike and Certain Exhibits to Declaration of Louis E. Fogel in Support Thereto (Fogel, Louis) 250 Filed & Entered: 02/25/2022 response in opposition to motion Docket Text: RESPONSE by Alvotech hf.in Opposition to MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to strike Defendant's Final Invalidity and Uneforceability Contentions[241] / Defendant Alvotech hf.'s Opposition to Plaintiffs' Motion to Strike (Attachments: # (1) Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opposition to Plaintiffs' Motion to Strike, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F - Filed Under Seal, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K - Filed Under Seal)(Fogel, Louis) 251 Filed & Entered: 02/25/2022 sealed response Docket Text: SEALED RESPONSE by Alvotech hf. to MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to strike Defendant's Final Invalidity and Uneforceability Contentions[241] ] / Defendant Alvotech hf.'s Opposition to Plaintiffs' Motion to Strike (Attachments: # (1) Exhibit F, # (2) Exhibit G, # (3) Exhibit K)(Fogel, Louis) 252 Filed & Entered: 02/28/2022Terminated: 03/02/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19199820. (Kestle, Sydney) 253 Filed & Entered: 03/01/2022 reply Docket Text: REPLY by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to motion to strike[241] (Attachments: # (1) Index of Exhibits to Plaintiffs' Reply in Support of Motion to Strike Defendant's Final Invalidity and Unenforceability Contentions, # (2) Exhibit 1, # (3) Exhibit 2)(Morin, Michael) 254 Filed & Entered: 03/02/2022 order on motion to appear pro hac vice Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion to appear pro hac vice by Sydney Kestle [252] is granted. (ca, ) 255 Filed & Entered: 03/02/2022Terminated: 03/04/2022 motion for miscellaneous relief Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for Appointment of Commissioners, and Direction of Submission of Hague Convention Application for Authorization of the Duly Appointed Commissioners to take Evidence Pursuant to Article 17 of the Hague Convention (Unopposed) (Attachments: # (1) Appendix A, # (2) Exhibit 1)(Morin, Michael) 256 Filed & Entered: 03/02/2022Terminated: 03/04/2022 motion to appear pro hac vice Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-19209213. (McCormick, Madelyn) 257 Filed & Entered: 03/04/2022 order on motion to appear pro hac vice Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion to appear pro hac vice by Madelyn McCormick [256] is granted. (ca, ) 258 Filed & Entered: 03/04/2022 order on motion for miscellaneous relief Docket Text: MINUTE entry before the Honorable M. David Weisman: Plaintiff's unopposed motion for appointment of commissioners, and direction of submission of hague convention application for authorization of the duly appointed commissioners to take evidence pursuant to article 17 of the hague convention of 18 March 1970 on the taking of evidence abroad in civil or commercial matters [225] is granted. Enter order. Mailed notice (ao, ) 259 Filed & Entered: 03/04/2022 order Docket Text: ORDER: Signed by the Honorable M. David Weisman on 3/4/2022. Mailed notice (ao, ) 260 Filed & Entered: 03/04/2022 terminate hearings Docket Text: MINUTE entry before the Honorable M. David Weisman: After consultation with the district court the 3/4/22 status hearing is reset to 3/15/22 at 11:00 a.m. This Court will set a discovery schedule consistent with any modifications made by the district court in its schedule. Parties shall dial in using the Court's conference call-in number. The conference call- in number is 1-877-411-9748 and the passcode is 1814539. Mailed notice (ao, ) 261 Filed & Entered: 03/04/2022 text entry Docket Text: MINUTE entry before the Honorable John Z. Lee:All deadlines are stayed pending scheduling decisions at the next status hearing on 3/15/22. (ca, ) 262 Filed & Entered: 03/09/2022 stipulation of dismissal Docket Text: STIPULATION of Dismissal (Joint) (Berkowitz, Sean) 263 Filed & Entered: 03/09/2022 terminate hearings Docket Text: MINUTE entry before the Honorable M. David Weisman: In light of the stipulation to dismiss [262], all matters relating to the referral of this case having been resolved, this matter is returned to the District Judge. Status hearing set for 3/4/22 before Magistrate Judge Weisman is hereby stricken with no appearance required. Referral terminated. Mailed notice (ao, ) 264 Filed & Entered: 03/09/2022 terminated case Docket Text: MINUTE entry before the Honorable John Z. Lee:Pursuant to the joint stipulation of dismissal, this case is dismissed without prejudice with each party to bear its own attorneys' fees and costs. Civil case terminated. (ca, ) |
| Dec 30, 2021 | 139 | order on motion for leave to file (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for leave to file under seal [135] is granted. (ca, ) |
| Dec 29, 2021 | 138 | motion to dismiss (4) Docket Text: MOTION by Defendant Alvotech hf. to dismiss / Defendant Alvotech hf.'s Renewed Rule 12(B)(1), 12(B)(2), 12(B)(6), and 12(B)(7) Motion to Dismiss for Lack of Subject Matter Jurisdiction, Lack of Personal Jurisdiction, Failure to State a Claim, and Failure to Join a Necessary Party (Fogel, Louis) |
| Dec 27, 2021 | 134 | order on motion to seal (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for leave to file under seal [124] is granted. (ca, ) |
| Dec 27, 2021 | 135 | motion for leave to file (5) Docket Text: MOTION by Defendant Alvotech hf. for leave to file under seal portions of defendant Alvotech Hf.'s quarterly regulatory update per dkt [63] and the exhibit thereto (Fogel, Louis) |
| Dec 27, 2021 | 137 | other (Main Document) (5) Docket Text: Defendant Alvotech Hf.'s Quarterly Regulatory Update per dkt [63] (public version) by Alvotech hf. (Attachments: # (1) Exhibit A)(Fogel, Louis) |
| Dec 27, 2021 | 137 | other (Exhibit A) (1) Docket Text: Defendant Alvotech Hf.'s Quarterly Regulatory Update per dkt [63] (public version) by Alvotech hf. (Attachments: # (1) Exhibit A)(Fogel, Louis) |
| Dec 22, 2021 | 132 | order on motion to compel (1) Docket Text: MINUTE entry before the Honorable M. David Weisman: Unopposed motion to withdraw plaintiffs' motion to compel discovery responses [128] is granted. Plaintiffs' motion to compel discovery responses [73] is withdrawn. Mailed notice. (pk, ) |
| Dec 22, 2021 | 133 | status report (10) Docket Text: STATUS Report and Claim Construction Chart (Joint) by Alvotech hf. (Fogel, Louis) |
| Dec 21, 2021 | 1 | Amended Complaint* (1) |
| Dec 21, 2021 | 129 | order on motion to appear pro hac vice (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion to appear pro hac vice by Cecilia Sanabria [127] is granted. (ca, ) |
| Dec 21, 2021 | 130 | amended complaint (Main Document) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Index of Exhibits) (5) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 1-16) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 17-23) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 24-30) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 31-37) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 38-42) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 43-49) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 50-55) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 56-59) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 60-63) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 64-67) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 130 | amended complaint (Exhibits 68-71) (30) Docket Text: Second AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-71)(Berkowitz, Sean) |
| Dec 21, 2021 | 131 | other (6) Docket Text: Local Rule 3.4 Notice of Claim Involving United States Patent by AbbVie Biotechnology Ltd, AbbVie Inc. (Berkowitz, Sean) |
| Dec 20, 2021 | 127 | motion to appear pro hac vice (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18987376. (Sanabria, Cecilia) |
| Dec 20, 2021 | 128 | motion to withdraw (6) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to withdraw Plaintiffs' Motion to Compel Discovery Responses (Unopposed) (Berkowitz, Sean) |
| Dec 17, 2021 | 124 | motion to seal (6) Docket Text: MOTION by Defendant Alvotech hf. to seal / Defendant Alvotech hf.'s Motion for Leave to File Under Seal Portions of Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(a) and Certain Exhibits to the Declaration Prepared in Support Thereof (Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Main Document) (22) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Declaration Louis E. Fogel) (2) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 18) (1) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 19) (1) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 20) (30) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 21) (27) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 22) (1) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 23) (1) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 24) (1) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 25) (1) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 26) (1) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 17, 2021 | 125 | reply (Exhibit 27) (5) Docket Text: REPLY by Defendant Alvotech hf. / Defendant Alvotech hf.'s Reply Claim Construction Brief Pursuant to LPR 4.2(d) (Attachments: # (1) Declaration Louis E. Fogel, # (2) Exhibit 18, # (3) Exhibit 19, # (4) Exhibit 20, # (5) Exhibit 21, # (6) Exhibit 22, # (7) Exhibit 23, # (8) Exhibit 24, # (9) Exhibit 25, # (10) Exhibit 26, # (11) Exhibit 27)(Fogel, Louis) |
| Dec 15, 2021 | 123 | order on motion for leave to file (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for leave to file under seal [92] is granted. (ca, ) |
| Dec 13, 2021 | 122 | exhibit (Main Document) (3) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 13, 2021 | 122 | exhibit (Exhibit A) (24) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 13, 2021 | 122 | exhibit (Exhibit B) (7) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 13, 2021 | 122 | exhibit (Exhibit G) (7) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 13, 2021 | 122 | exhibit (Exhibit H) (24) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 13, 2021 | 122 | exhibit (Exhibit I) (5) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 13, 2021 | 122 | exhibit (Exhibit N) (11) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 13, 2021 | 122 | exhibit (Exhibit O) (7) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 13, 2021 | 122 | exhibit (Exhibit P) (4) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 13, 2021 | 122 | exhibit (Exhibit R) (30) Docket Text: EXHIBIT by Defendant Alvotech hf. / Defendant Alvotech hf.'s Public, Redacted Exhibits in Support of Response to Plaintiffs' Motion to Compel Discovery Responses regarding exhibit, [119] (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit G, # (4) Exhibit H, # (5) Exhibit I, # (6) Exhibit N, # (7) Exhibit O, # (8) Exhibit P, # (9) Exhibit R)(Fogel, Louis) |
| Dec 9, 2021 | 121 | response in opposition to motion (4) Docket Text: RESPONSE by AbbVie Biotechnology Ltd, AbbVie Inc. in Opposition to MOTION by Defendant Alvotech hf. to dismiss FOR LACK OF SUBJECT MATTER JURISDICTION, LACK OF PERSONAL JURISDICTION, FAILURE TO STATE A CLAIM, AND FAILURE TO JOIN A NECESSARY PARTY RULE 12(B)(1), 12(B)(2), 12(B)(6), AND 12(B)(7) (Renewed)[91] (Morin, Michael) |
| Dec 7, 2021 | 120 | order on motion to seal (1) Docket Text: MINUTE entry before the Honorable M. David Weisman: Defendant Alvotech hf.'s motion for leave to file under seal certain exhibits to the declaration of Esha Bandyopadhyay filed in support of Alvotech hf.'s response to plaintiffs' motion to compel discovery responses[116] is granted. The Court notes that the sealed exhibits were filed on 12/6/21 [119]. Defendant Alvotech hf. is ordered to file on the public docket a redacted version of the exhibits filed under seal at [119]. Mailed notice. (pk, ) |
| Dec 6, 2021 | 115 | set/reset hearings (1) Docket Text: MINUTE entry before the Honorable M. David Weisman:This case has been referred to Magistrate Judge Weisman for the purposes of discovery supervision [87][88].Initial status/ruling on motion hearing on plaintiffs' motion to compel discovery responses [73] scheduled for 1/24/22 at 9:15 a.m. Prior to the status hearing, the Court specifically requests that counsel consult the Court's standing order. Parties should be prepared to discuss discovery scheduling and related issues. Parties shall dial in using the Court's conference call-in number. The conference call- in number is 1-877-411-9748 and the passcode is 1814539. Mailed notice. (pk, ) |
| Dec 6, 2021 | 116 | motion to seal (7) Docket Text: MOTION by Defendant Alvotech hf. to seal / Defendant Alvotech HF.'s Motion for Leave to File Under Seal Certain Exhibits to the Declaration of Esha Bandyopadhyay Filed in Support of Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses (Fogel, Louis) |
| Dec 6, 2021 | 117 | response to motion (19) Docket Text: RESPONSE by Alvotech hf. to MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to compel discovery responses[73] / Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses (Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Main Document) (5) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit A - Filed Under Seal) (1) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit B - Filed Under Seal) (1) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit C) (6) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit D) (5) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit E) (30) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit F) (30) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit G - Filed Under Seal) (1) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit H - Filed Under Seal) (1) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit I - Filed Under Seal) (1) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit J) (6) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit K) (5) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit L) (11) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit M) (16) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit N - Filed Under Seal) (1) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit O - Filed Under Seal) (1) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit P - Filed Under Seal) (1) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit Q) (19) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 6, 2021 | 118 | declaration (Exhibit R - Filed Under Seal) (1) Docket Text: DECLARATION of Esha Bandyopadhyay in Support of Defendant Alvotech HF.'s Response to Plaintiffs' Motion to Compel Discovery Responses regarding response to motion, [117] (Attachments: # (1) Exhibit A - Filed Under Seal, # (2) Exhibit B - Filed Under Seal, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G - Filed Under Seal, # (8) Exhibit H - Filed Under Seal, # (9) Exhibit I - Filed Under Seal, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N - Filed Under Seal, # (15) Exhibit O - Filed Under Seal, # (16) Exhibit P - Filed Under Seal, # (17) Exhibit Q, # (18) Exhibit R - Filed Under Seal)(Fogel, Louis) |
| Dec 4, 2021 | 109 | other (Main Document) (3) Docket Text: Exhibit 13 (part 9) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 9)(Berkowitz, Sean) |
| Dec 4, 2021 | 109 | other (Exhibit 13- Part 9) (30) Docket Text: Exhibit 13 (part 9) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 9)(Berkowitz, Sean) |
| Dec 4, 2021 | 110 | other (Main Document) (3) Docket Text: Exhibits 14-17 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 14, # (2) Exhibit 15, # (3) Exhibit 16, # (4) Exhibit 17)(Morin, Michael) |
| Dec 4, 2021 | 110 | other (Exhibit 14) (9) Docket Text: Exhibits 14-17 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 14, # (2) Exhibit 15, # (3) Exhibit 16, # (4) Exhibit 17)(Morin, Michael) |
| Dec 4, 2021 | 110 | other (Exhibit 15) (10) Docket Text: Exhibits 14-17 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 14, # (2) Exhibit 15, # (3) Exhibit 16, # (4) Exhibit 17)(Morin, Michael) |
| Dec 4, 2021 | 110 | other (Exhibit 16) (8) Docket Text: Exhibits 14-17 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 14, # (2) Exhibit 15, # (3) Exhibit 16, # (4) Exhibit 17)(Morin, Michael) |
| Dec 4, 2021 | 110 | other (Exhibit 17) (12) Docket Text: Exhibits 14-17 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 14, # (2) Exhibit 15, # (3) Exhibit 16, # (4) Exhibit 17)(Morin, Michael) |
| Dec 4, 2021 | 111 | other (Main Document) (3) Docket Text: Exhibits 18-22 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 18, # (2) Exhibit 19, # (3) Exhibit 20, # (4) Exhibit 21, # (5) Exhibit 22)(Berkowitz, Sean) |
| Dec 4, 2021 | 111 | other (Exhibit 18) (30) Docket Text: Exhibits 18-22 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 18, # (2) Exhibit 19, # (3) Exhibit 20, # (4) Exhibit 21, # (5) Exhibit 22)(Berkowitz, Sean) |
| Dec 4, 2021 | 111 | other (Exhibit 19) (1) Docket Text: Exhibits 18-22 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 18, # (2) Exhibit 19, # (3) Exhibit 20, # (4) Exhibit 21, # (5) Exhibit 22)(Berkowitz, Sean) |
| Dec 4, 2021 | 111 | other (Exhibit 20) (30) Docket Text: Exhibits 18-22 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 18, # (2) Exhibit 19, # (3) Exhibit 20, # (4) Exhibit 21, # (5) Exhibit 22)(Berkowitz, Sean) |
| Dec 4, 2021 | 111 | other (Exhibit 21) (1) Docket Text: Exhibits 18-22 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 18, # (2) Exhibit 19, # (3) Exhibit 20, # (4) Exhibit 21, # (5) Exhibit 22)(Berkowitz, Sean) |
| Dec 4, 2021 | 111 | other (Exhibit 22) (1) Docket Text: Exhibits 18-22 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 18, # (2) Exhibit 19, # (3) Exhibit 20, # (4) Exhibit 21, # (5) Exhibit 22)(Berkowitz, Sean) |
| Dec 4, 2021 | 112 | other (Main Document) (3) Docket Text: Exhibits 23-27 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 23, # (2) Exhibit 24, # (3) Exhibit 25, # (4) Exhibit 26, # (5) Exhibit 27)(Morin, Michael) |
| Dec 4, 2021 | 112 | other (Exhibit 23) (30) Docket Text: Exhibits 23-27 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 23, # (2) Exhibit 24, # (3) Exhibit 25, # (4) Exhibit 26, # (5) Exhibit 27)(Morin, Michael) |
| Dec 4, 2021 | 112 | other (Exhibit 24) (17) Docket Text: Exhibits 23-27 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 23, # (2) Exhibit 24, # (3) Exhibit 25, # (4) Exhibit 26, # (5) Exhibit 27)(Morin, Michael) |
| Dec 4, 2021 | 112 | other (Exhibit 25) (9) Docket Text: Exhibits 23-27 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 23, # (2) Exhibit 24, # (3) Exhibit 25, # (4) Exhibit 26, # (5) Exhibit 27)(Morin, Michael) |
| Dec 4, 2021 | 112 | other (Exhibit 26) (7) Docket Text: Exhibits 23-27 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 23, # (2) Exhibit 24, # (3) Exhibit 25, # (4) Exhibit 26, # (5) Exhibit 27)(Morin, Michael) |
| Dec 4, 2021 | 112 | other (Exhibit 27) (7) Docket Text: Exhibits 23-27 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 23, # (2) Exhibit 24, # (3) Exhibit 25, # (4) Exhibit 26, # (5) Exhibit 27)(Morin, Michael) |
| Dec 4, 2021 | 113 | other (Main Document) (3) Docket Text: Exhibits 28-33 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32, # (6) Exhibit 33)(Berkowitz, Sean) |
| Dec 4, 2021 | 113 | other (Exhibit 28) (7) Docket Text: Exhibits 28-33 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32, # (6) Exhibit 33)(Berkowitz, Sean) |
| Dec 4, 2021 | 113 | other (Exhibit 29) (10) Docket Text: Exhibits 28-33 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32, # (6) Exhibit 33)(Berkowitz, Sean) |
| Dec 4, 2021 | 113 | other (Exhibit 30) (2) Docket Text: Exhibits 28-33 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32, # (6) Exhibit 33)(Berkowitz, Sean) |
| Dec 4, 2021 | 113 | other (Exhibit 31) (7) Docket Text: Exhibits 28-33 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32, # (6) Exhibit 33)(Berkowitz, Sean) |
| Dec 4, 2021 | 113 | other (Exhibit 32) (5) Docket Text: Exhibits 28-33 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32, # (6) Exhibit 33)(Berkowitz, Sean) |
| Dec 4, 2021 | 113 | other (Exhibit 33) (1) Docket Text: Exhibits 28-33 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 28, # (2) Exhibit 29, # (3) Exhibit 30, # (4) Exhibit 31, # (5) Exhibit 32, # (6) Exhibit 33)(Berkowitz, Sean) |
| Dec 3, 2021 | 91 | motion to dismiss (4) Docket Text: MOTION by Defendant Alvotech hf. to dismiss FOR LACK OF SUBJECT MATTER JURISDICTION, LACK OF PERSONAL JURISDICTION, FAILURE TO STATE A CLAIM, AND FAILURE TO JOIN A NECESSARY PARTY RULE 12(B)(1), 12(B)(2), 12(B)(6), AND 12(B)(7) (Renewed) (Fogel, Louis) |
| Dec 3, 2021 | 92 | motion for leave to file (7) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for leave to file under seal (Morin, Michael) |
| Dec 3, 2021 | 93 | declaration (Main Document) (22) Docket Text: DECLARATION of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd's Responsive Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6)(Morin, Michael) |
| Dec 3, 2021 | 93 | declaration (Index of Exhibits to Declaration of Charles E. Clemens in Support of Abbvie Inc) (1) Docket Text: DECLARATION of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd's Responsive Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6)(Morin, Michael) |
| Dec 3, 2021 | 93 | declaration (Exhibit 1) (2) Docket Text: DECLARATION of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd's Responsive Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6)(Morin, Michael) |
| Dec 3, 2021 | 93 | declaration (Exhibit 2) (13) Docket Text: DECLARATION of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd's Responsive Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6)(Morin, Michael) |
| Dec 3, 2021 | 93 | declaration (Exhibit 3) (4) Docket Text: DECLARATION of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd's Responsive Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6)(Morin, Michael) |
| Dec 3, 2021 | 93 | declaration (Exhibit 4) (4) Docket Text: DECLARATION of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd's Responsive Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6)(Morin, Michael) |
| Dec 3, 2021 | 93 | declaration (Exhibit 5) (4) Docket Text: DECLARATION of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd's Responsive Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6)(Morin, Michael) |
| Dec 3, 2021 | 93 | declaration (Exhibit 6) (4) Docket Text: DECLARATION of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd's Responsive Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Charles E. Clemens in Support of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3, # (5) Exhibit 4, # (6) Exhibit 5, # (7) Exhibit 6)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Main Document) (30) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintif) (2) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit A) (10) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit B) (3) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit C) (13) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit D) (7) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit E) (3) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit F) (7) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit G) (7) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit H) (8) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit I) (5) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit J) (30) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit K) (30) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit L) (30) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit M) (30) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit N) (24) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit O) (7) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit P) (3) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit Q) (13) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 95 | declaration (Exhibit R) (7) Docket Text: DECLARATION of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief (Attachments: # (1) Index of Exhibits to Declaration of Dr. Howard L. Levine in Support of Plaintiffs' Claim Construction Brief, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O, # (17) Exhibit P, # (18) Exhibit Q, # (19) Exhibit R)(Morin, Michael) |
| Dec 3, 2021 | 97 | other (Main Document) (30) Docket Text: Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Index of Exhibits to Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Morin, Michael) |
| Dec 3, 2021 | 97 | other (Index of Exhibits to Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsiv) (3) Docket Text: Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Index of Exhibits to Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Morin, Michael) |
| Dec 3, 2021 | 97 | other (Exhibit 1) (27) Docket Text: Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Index of Exhibits to Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Morin, Michael) |
| Dec 3, 2021 | 97 | other (Exhibit 2) (22) Docket Text: Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Index of Exhibits to Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Morin, Michael) |
| Dec 3, 2021 | 97 | other (Exhibit 3) (18) Docket Text: Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Index of Exhibits to Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Morin, Michael) |
| Dec 3, 2021 | 98 | other (Main Document) (3) Docket Text: Exhibit 4-5 (part 1) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 4, # (2) Exhibit 5 - Part 1)(Berkowitz, Sean) |
| Dec 3, 2021 | 98 | other (Exhibit 4) (9) Docket Text: Exhibit 4-5 (part 1) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 4, # (2) Exhibit 5 - Part 1)(Berkowitz, Sean) |
| Dec 3, 2021 | 98 | other (Exhibit 5 - Part 1) (30) Docket Text: Exhibit 4-5 (part 1) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 4, # (2) Exhibit 5 - Part 1)(Berkowitz, Sean) |
| Dec 3, 2021 | 99 | other (Main Document) (3) Docket Text: Exhibit 5 (part 2) - 8 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 5- Part 2, # (2) Exhibit 6, # (3) Exhibit 7, # (4) Exhibit 8)(Berkowitz, Sean) |
| Dec 3, 2021 | 99 | other (Exhibit 5- Part 2) (30) Docket Text: Exhibit 5 (part 2) - 8 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 5- Part 2, # (2) Exhibit 6, # (3) Exhibit 7, # (4) Exhibit 8)(Berkowitz, Sean) |
| Dec 3, 2021 | 99 | other (Exhibit 6) (1) Docket Text: Exhibit 5 (part 2) - 8 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 5- Part 2, # (2) Exhibit 6, # (3) Exhibit 7, # (4) Exhibit 8)(Berkowitz, Sean) |
| Dec 3, 2021 | 99 | other (Exhibit 7) (30) Docket Text: Exhibit 5 (part 2) - 8 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 5- Part 2, # (2) Exhibit 6, # (3) Exhibit 7, # (4) Exhibit 8)(Berkowitz, Sean) |
| Dec 3, 2021 | 99 | other (Exhibit 8) (1) Docket Text: Exhibit 5 (part 2) - 8 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 5- Part 2, # (2) Exhibit 6, # (3) Exhibit 7, # (4) Exhibit 8)(Berkowitz, Sean) |
| Dec 3, 2021 | 100 | other (Main Document) (3) Docket Text: Exhibits 9- 12 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 9, # (2) Exhibit 10, # (3) Exhibit 11, # (4) Exhibit 12)(Berkowitz, Sean) |
| Dec 3, 2021 | 100 | other (Exhibit 9) (26) Docket Text: Exhibits 9- 12 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 9, # (2) Exhibit 10, # (3) Exhibit 11, # (4) Exhibit 12)(Berkowitz, Sean) |
| Dec 3, 2021 | 100 | other (Exhibit 10) (17) Docket Text: Exhibits 9- 12 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 9, # (2) Exhibit 10, # (3) Exhibit 11, # (4) Exhibit 12)(Berkowitz, Sean) |
| Dec 3, 2021 | 100 | other (Exhibit 11) (27) Docket Text: Exhibits 9- 12 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 9, # (2) Exhibit 10, # (3) Exhibit 11, # (4) Exhibit 12)(Berkowitz, Sean) |
| Dec 3, 2021 | 100 | other (Exhibit 12) (23) Docket Text: Exhibits 9- 12 of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 9, # (2) Exhibit 10, # (3) Exhibit 11, # (4) Exhibit 12)(Berkowitz, Sean) |
| Dec 3, 2021 | 101 | other (Main Document) (3) Docket Text: Exhibit 13 (part 1) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Bri by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit Exhibit 13- Part 1)(Berkowitz, Sean) |
| Dec 3, 2021 | 101 | other (Exhibit Exhibit 13- Part 1) (30) Docket Text: Exhibit 13 (part 1) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Bri by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit Exhibit 13- Part 1)(Berkowitz, Sean) |
| Dec 3, 2021 | 102 | other (Main Document) (3) Docket Text: Exhibit 13 (Part 2) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 2)(Berkowitz, Sean) |
| Dec 3, 2021 | 102 | other (Exhibit 13- Part 2) (30) Docket Text: Exhibit 13 (Part 2) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 2)(Berkowitz, Sean) |
| Dec 3, 2021 | 103 | other (Main Document) (3) Docket Text: Exhibit 13 (part 3) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 3)(Berkowitz, Sean) |
| Dec 3, 2021 | 103 | other (Exhibit 13- Part 3) (30) Docket Text: Exhibit 13 (part 3) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 3)(Berkowitz, Sean) |
| Dec 3, 2021 | 104 | other (Main Document) (3) Docket Text: Exhibit 13 (part 4) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 4)(Morin, Michael) |
| Dec 3, 2021 | 104 | other (Exhibit 13- Part 4) (30) Docket Text: Exhibit 13 (part 4) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 4)(Morin, Michael) |
| Dec 3, 2021 | 105 | other (Main Document) (3) Docket Text: Exhibit 13 (part 5) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 5)(Berkowitz, Sean) |
| Dec 3, 2021 | 105 | other (Exhibit 13- Part 5) (30) Docket Text: Exhibit 13 (part 5) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 5)(Berkowitz, Sean) |
| Dec 3, 2021 | 106 | other (Main Document) (3) Docket Text: Exhibit 13 (part 6) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 6)(Morin, Michael) |
| Dec 3, 2021 | 106 | other (Exhibit 13- Part 6) (30) Docket Text: Exhibit 13 (part 6) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 6)(Morin, Michael) |
| Dec 3, 2021 | 107 | other (Main Document) (3) Docket Text: Exhibit 13 (part 7) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 7)(Berkowitz, Sean) |
| Dec 3, 2021 | 107 | other (Exhibit 13- Part 7) (30) Docket Text: Exhibit 13 (part 7) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 7)(Berkowitz, Sean) |
| Dec 3, 2021 | 108 | other (Main Document) (3) Docket Text: Exhibit 13 (part 8) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 8)(Morin, Michael) |
| Dec 3, 2021 | 108 | other (Exhibit 13- Part 8) (30) Docket Text: Exhibit 13 (part 8) of Abbvie Inc. and Abbvie Biotechnology Ltd.'s Responsive Claim Construction Brief by AbbVie Biotechnology Ltd, AbbVie Inc. (Attachments: # (1) Exhibit 13- Part 8)(Morin, Michael) |
| Nov 24, 2021 | 90 | order on motion for extension of time to answer (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for extension of time until December 3, 2021 to answer the first amended complaint [89] is granted. (ca, ) |
| Nov 23, 2021 | 89 | motion for extension of time to file answer (3) Docket Text: MOTION by Defendant Alvotech hf. for extension of time to file answer / Unopposed Motion for an Extension of Time for Defendant to Answer the First Amended Complaint (Fogel, Louis) |
| Nov 22, 2021 | 85 | order on motion for leave to file (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for leave to file under seal[72] is granted. (ca, ) |
| Nov 22, 2021 | 86 | order (4) Docket Text: STIPULATION and order regarding Defendant Alvotech HF.'s motion to compel discovery responses. Signed by the Honorable John Z. Lee on 11/22/21.(ca, ) |
| Nov 22, 2021 | 87 | text entry (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:This case is referred to Magistrate Judge Weisman for general discovery supervision. (ca, ) |
| Nov 22, 2021 | 88 | Expedited referral to magistrate judge (1) Docket Text: Pursuant to Local Rule 72.1, this case is hereby referred to the calendar of Honorable M. David Weisman for the purpose of holding proceedings related to: general discovery supervision.(ca, ) |
| Nov 19, 2021 | 80 | other (30) Docket Text: Opening Claim Construction Brief Pursuant to LPR 4.2(a) by Alvotech hf. (Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Main Document) (5) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 1) (17) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 2) (6) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 3) (12) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 4) (30) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 5) (19) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 6) (30) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 7) (4) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 8) (4) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 9) (4) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 10) (30) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 11) (10) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 12) (8) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 13) (8) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 14) (12) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 15) (10) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 16) (4) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 81 | declaration (Exhibit 17) (13) Docket Text: DECLARATION of Louis E. Fogel regarding other[80] / Declaration of Louis E. Fogel in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10, # (11) Exhibit 11, # (12) Exhibit 12, # (13) Exhibit 13, # (14) Exhibit 14, # (15) Exhibit 15, # (16) Exhibit 16, # (17) Exhibit 17)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Main Document) (26) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit A) (17) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit B) (3) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit C) (21) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit D) (5) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit E) (13) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit F) (5) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit G) (8) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit H) (9) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit I) (30) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit J) (9) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit K) (9) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit L) (8) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 82 | declaration (Exhibit M) (13) Docket Text: DECLARATION of Dr. Abraham Lenhoff regarding other[80] / Declaration of Dr. Abraham Lenhoff in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Main Document) (22) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit A) (23) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit B) (5) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit C) (3) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit D) (30) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit E) (4) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit F) (4) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit G) (4) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit H) (5) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit I) (4) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit J) (4) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit K) (3) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit L) (13) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit M) (21) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit N) (12) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit O) (17) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit P) (4) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit Q) (8) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit R) (30) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit S) (4) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit T) (30) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit U) (30) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit V) (5) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit W) (4) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit X) (6) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit Y) (4) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 83 | declaration (Exhibit Z) (5) Docket Text: DECLARATION of Dr. Charles Reinholtz, Ph.D. regarding other[80] / Declaration of Dr. Charles Reinholtz, Ph.D. in Support of Alvotech hf.'s Opening Claim Construction Brief (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Exhibit V, # (23) Exhibit W, # (24) Exhibit X, # (25) Exhibit Y, # (26) Exhibit Z)(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Main Document) (5) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 1) (23) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 2) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 3) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 4) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 4 (Part 2)) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 4 (Part 3)) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 5) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 6) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 7) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 8) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 9) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 10) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 10 (Part 2)) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 10 (Part 3)) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 19, 2021 | 84 | appendix (Joint Appendix 10 (Part 4)) (30) Docket Text: APPENDIX other[80] / Joint Claim Construction Appendix Pursuant to LPR 4.2(b) (Attachments: # (1) Joint Appendix 1, # (2) Joint Appendix 2, # (3) Joint Appendix 3, # (4) Joint Appendix 4, # (5) Joint Appendix 4 (Part 2), # (6) Joint Appendix 4 (Part 3), # (7) Joint Appendix 5, # (8) Joint Appendix 6, # (9) Joint Appendix 7, # (10) Joint Appendix 8, # (11) Joint Appendix 9, # (12) Joint Appendix 10, # (13) Joint Appendix 10 (Part 2), # (14) Joint Appendix 10 (Part 3), # (15) Joint Appendix 10 (Part 4))(Fogel, Louis) |
| Nov 15, 2021 | 79 | stipulation (4) Docket Text: STIPULATION regarding motion to compel, [61] / Stipulation and Proposed Order regarding Defendant Alvotech hf.'s Motion to Compel Discovery Responses (Fogel, Louis) |
| Nov 12, 2021 | 1 | Amended Complaint* (1) |
| Nov 12, 2021 | 77 | amended complaint (Main Document) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Index of Exhibits) (4) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 1-16) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 17-23) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 24-30) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 31-37) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 38-42) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 43-49) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 50-55) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 56-59) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 60-63) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 64-67) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 77 | amended complaint (Exhibits 68-70) (30) Docket Text: First AMENDED complaint by AbbVie Inc., AbbVie Biotechnology Ltd against Alvotech hf. (Attachments: # (1) Index of Exhibits, # (2) Exhibits 1-16, # (3) Exhibits 17-23, # (4) Exhibits 24-30, # (5) Exhibits 31-37, # (6) Exhibits 38-42, # (7) Exhibits 43-49, # (8) Exhibits 50-55, # (9) Exhibits 56-59, # (10) Exhibits 60-63, # (11) Exhibits 64-67, # (12) Exhibits 68-70)(Berkowitz, Sean) |
| Nov 12, 2021 | 78 | other (6) Docket Text: Local Rule 3.4 Notice of Claim Involving United States Patent by AbbVie Biotechnology Ltd, AbbVie Inc. (Berkowitz, Sean) |
| Nov 8, 2021 | 76 | set motion and R&R deadlines/hearings (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: Defendant to file a response to plaintiffs' motion to compel [73] by 12/6/2021. Plaintiffs to file a reply by 12/20/2021. Mailed notice. (ym, ) |
| Nov 5, 2021 | 71 | order on motion for leave to file excess pages (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: Joint motion for excess pages for opening and responsive claim construction briefs [70] is granted. The parties have leave to file opening and responsive claim construction briefs of up to thirty pages. Mailed notice (cn). |
| Nov 5, 2021 | 72 | motion for leave to file (6) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for leave to file under seal (Berkowitz, Sean) |
| Nov 5, 2021 | 73 | motion to compel (20) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to compel discovery responses (Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Main Document) (2) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Index of Exhibits) (1) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Exhibit A) (6) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Exhibit B) (8) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Exhibit C - Filed Under Seal) (1) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Exhibit D) (11) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Exhibit E - Filed Under Seal) (1) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Exhibit F) (12) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Exhibit G - Filed Under Seal) (1) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 5, 2021 | 74 | declaration (Exhibit H) (4) Docket Text: DECLARATION of Oulu Wang regarding motion to compel[73] discovery responses (Attachments: # (1) Index of Exhibits, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C - Filed Under Seal, # (5) Exhibit D, # (6) Exhibit E - Filed Under Seal, # (7) Exhibit F, # (8) Exhibit G - Filed Under Seal, # (9) Exhibit H)(Berkowitz, Sean) |
| Nov 4, 2021 | 70 | motion for leave to file excess pages (5) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for leave to file excess pages for Opening and Responsive Claim Construction Briefs (Joint) (Berkowitz, Sean) |
| Nov 3, 2021 | 69 | order on motion to seal (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: Defendant's amended motion for leave to file under seal [68] is granted. The Court strikes defendant's motion for leave to file under seal [60] as moot. (rao, ) |
| Nov 2, 2021 | 68 | motion to seal (5) Docket Text: MOTION by Defendant Alvotech hf. to seal / Defendant Alvotech hf.'s Amended Motion For Leave To File Under Seal re [60] (Fogel, Louis) |
| Nov 1, 2021 | 67 | set motion and R&R deadlines/hearings (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: Plaintiffs' response to defendant Alvotech hf's motion to compel discovery responses [61] is due by 11/22/2021. (rao, ) |
| Oct 29, 2021 | 60 | motion to seal (4) Docket Text: MOTION by Defendant Alvotech hf. to seal / Defendant Alvotech hf.'s Motion for Leave to File Under Seal (Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Main Document) (17) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit 1) (4) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit A) (1) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit B) (1) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit C) (18) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit D) (16) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit E) (3) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit F) (1) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit G) (1) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit H) (12) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit I) (1) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit J) (3) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit K) (7) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit L) (9) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit M) (12) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit N) (9) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 29, 2021 | 61 | motion to compel (Exhibit O) (10) Docket Text: MOTION by Defendant Alvotech hf. to compel discovery responses (Attachments: # (1) Exhibit 1, # (2) Exhibit A, # (3) Exhibit B, # (4) Exhibit C, # (5) Exhibit D, # (6) Exhibit E, # (7) Exhibit F, # (8) Exhibit G, # (9) Exhibit H, # (10) Exhibit I, # (11) Exhibit J, # (12) Exhibit K, # (13) Exhibit L, # (14) Exhibit M, # (15) Exhibit N, # (16) Exhibit O)(Fogel, Louis) |
| Oct 6, 2021 | 58 | order on motion to appear pro hac vice (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: Motion to appear pro hac vice by Mark Buscher [57] is granted. (ca, ) |
| Oct 6, 2021 | 59 | attorney appearance (1) Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by Mark R Buscher (Buscher, Mark) |
| Oct 5, 2021 | 57 | motion to appear pro hac vice (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18740403. (Buscher, Mark) |
| Sep 28, 2021 | 55 | order on motion for miscellaneous relief (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:Joint motion for entry of a protective order [54] is granted. (ca, ) |
| Sep 28, 2021 | 56 | protective order (30) Docket Text: STIPULATED Protective Order Signed by the Honorable John Z. Lee on 9/28/21.(ca, ) |
| Sep 24, 2021 | 54 | motion for protective order (Main Document) (4) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for protective order (Joint) (Attachments: # (1) Exhibit 1)(Danek, Brenda) |
| Sep 24, 2021 | 54 | motion for protective order (Exhibit 1) (30) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for protective order (Joint) (Attachments: # (1) Exhibit 1)(Danek, Brenda) |
| Sep 20, 2021 | 52 | text entry (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: The Court orders the parties to file a joint written status report by 1/7/22. The report, which shall be as concise as possible, shall set forth: (1) the current deadlines imposed by the Court and whether the matter has been referred to the Magistrate Judge in any fashion (e.g., for discovery supervision; for resolution of a motion; for settlement; etc.); (2) the progress of discovery; (3) the status of briefing on unresolved motions, if any; (4) whether the parties have engaged or are engaging in settlement discussions and the status of those discussions; (5) for cases without any future court dates, an agreed proposed schedule; (6) for cases that have future court dates and if the parties believe there is good cause to extend the current deadlines, a proposed amended schedule and the basis for the request; (7) a request for any agreed action that the Court can take without a hearing; (8) and whether the parties believe a telephonic hearing or in-person hearing is necessary within the next 60 days, and, if so, the issue(s) that warrants discussion and the parties' respective positions. (ca, ) |
| Sep 20, 2021 | 53 | order (4) Docket Text: SCHEDULING and Discovery Order Signed by the Honorable John Z. Lee on 9/20/21.(ca, ) |
| Sep 14, 2021 | 50 | order on motion for extension of time (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:Motion for extension of time until September 14, 2021 to file the scheduling and discovery order [49] is granted. (ca, ) |
| Sep 14, 2021 | 51 | motion for miscellaneous relief (Main Document) (4) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for Entry of Scheduling and Discovery Order (Joint) (Attachments: # (1) Exhibit 1)(Berkowitz, Sean) |
| Sep 14, 2021 | 51 | motion for miscellaneous relief (Exhibit 1) (6) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for Entry of Scheduling and Discovery Order (Joint) (Attachments: # (1) Exhibit 1)(Berkowitz, Sean) |
| Sep 13, 2021 | 49 | extension of time (3) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. for extension of time to File Proposed Scheduling and Discovery Order (Unopposed) (Berkowitz, Sean) |
| Sep 2, 2021 | 47 | terminate hearings (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: The status hearing set for 9/2/21 at 9:30 a.m. is reset to 9/2/21 at 2:00 p.m. The telephone number for the public is 888-273-3658 and the access code is 1637578. Counsel of record will receive a separate email at least 12 hours prior to the start of the telephonic hearing with instructions on how to join the call. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, ) |
| Sep 2, 2021 | 48 | status hearing (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: Status hearing held on 9/2/21. The Court sets a bench trial commencing on August 1, 2022, as to the 10 patents to be selected by the parties. The parties should meet and confer and submit a proposed schedule as well as a list of the 10 patents at issue in a joint letter to the Court by 9/8/21 via email to: carmen_acevedo@ilnd.uscourts.gov. An informal video status conference via WebEx to discuss the schedule is set for 9/9/21 at 3:00 p.m. Counsel of record will receive log in information prior to the conference. Mailed notice. (ym, ) |
| Aug 27, 2021 | 46 | set/reset hearings (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:Status hearing set for 9/2/21 at 9:30 a.m. The telephone number for the public is 888-273-3658 and the access code is 1637578. Counsel of record will receive a separate email at least 12 hours prior to the start of the telephonic hearing with instructions on how to join the call. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, ) |
| Aug 18, 2021 | 45 | reply to response to motion (21) Docket Text: REPLY by Alvotech hf. to response in opposition to motion, [43] / Reply in Support of Defendant Alvotech Hf.'s Motion to Dismiss for Lack of Subject Matter Jurisdiction, Lack of Personal Jurisdiction, Failure to State a Claim, and Failure to Join a Necessary Party (Fogel, Louis) |
| Aug 13, 2021 | 42 | notice of filing (3) Docket Text: NOTICE by AbbVie Biotechnology Ltd, AbbVie Inc. re response in opposition to motion, [39] of Filing a Corrected Opposition to Defendants' Motion to Dismiss (Berkowitz, Sean) |
| Aug 13, 2021 | 43 | response in opposition to motion (22) Docket Text: RESPONSE by AbbVie Biotechnology Ltd, AbbVie Inc. in Opposition to MOTION by Defendant Alvotech hf. to dismiss FOR LACK OF SUBJECT MATTER JURISDICTION, LACK OF PERSONAL JURISDICTION, FAILURE TO STATE A CLAIM, AND FAILURE TO JOIN A NECESSARY PARTY RULE 12(B)(1), 12(B)(2), 12(B)(6), AND 12(B)(7)[28] (Corrected) (Berkowitz, Sean) |
| Aug 12, 2021 | 44 | status hearing (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: Status hearing held on 8/12/21. The Court will set a status after the ruling on the motion to dismiss is issued. (ca, ) |
| Aug 11, 2021 | 41 | motion for miscellaneous relief (4) Docket Text: MOTION by Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. to Amend Deadlines Under Local Patent Rules (Unopposed) (Danek, Brenda) |
| Aug 10, 2021 | 38 | text entry (1) Docket Text: MINUTE entry before the Honorable John Z. Lee:After further consideration, the hearing currently scheduled for 8/12/21 at 3:00 pm. will be held via video conference (using the Cisco WebEx platform), rather than in person. Defendant shall be allotted 20 minutes to present its arguments as to the motion to dismiss; Plaintiff then shall have 20 minutes to present its arguments in response; and Defendant shall have 5 minutes for rebuttal. Furthermore, the parties should be prepared to discuss the appropriate schedule for this case, as well as case no. 21-cv-02899. The courtroom deputy shall send counsel of record information on how to log into the hearing. The telephone number for the public is: 1-650-479-3207; Access code: 180 396 4573. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, ) |
| Aug 10, 2021 | 39 | response in opposition to motion (22) Docket Text: RESPONSE by AbbVie Biotechnology Ltd, AbbVie Inc. in Opposition to MOTION by Defendant Alvotech hf. to dismiss FOR LACK OF SUBJECT MATTER JURISDICTION, LACK OF PERSONAL JURISDICTION, FAILURE TO STATE A CLAIM, AND FAILURE TO JOIN A NECESSARY PARTY RULE 12(B)(1), 12(B)(2), 12(B)(6), AND 12(B)(7)[28] (Berkowitz, Sean) |
| Aug 10, 2021 | 40 | declaration (Main Document) (2) Docket Text: DECLARATION of Herman H. Yue regarding response in opposition to motion, [39] (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Yue, Herman) |
| Aug 10, 2021 | 40 | declaration (Index of Exhibits) (1) Docket Text: DECLARATION of Herman H. Yue regarding response in opposition to motion, [39] (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Yue, Herman) |
| Aug 10, 2021 | 40 | declaration (Exhibit 1) (5) Docket Text: DECLARATION of Herman H. Yue regarding response in opposition to motion, [39] (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Yue, Herman) |
| Aug 10, 2021 | 40 | declaration (Exhibit 2) (6) Docket Text: DECLARATION of Herman H. Yue regarding response in opposition to motion, [39] (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Yue, Herman) |
| Aug 10, 2021 | 40 | declaration (Exhibit 3) (5) Docket Text: DECLARATION of Herman H. Yue regarding response in opposition to motion, [39] (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1, # (3) Exhibit 2, # (4) Exhibit 3)(Yue, Herman) |
| Aug 5, 2021 | 37 | set/reset hearings (1) Docket Text: MINUTE entry before the Honorable John Z. Lee: Status hearing set for 8/12/21 at 3:00 p.m. in person, the court will set aside two hours for the hearing. The telephone number for the public is 888-273-3658 and the access code is 1637578. All persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in court-imposed sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. All participants should review the Court's standing order regarding telephone conferences that is on Judge Lee's website, which can be found at: https://www.ilnd.uscourts.gov/judge-info.aspx?4Qf5zc8loCI5U7rfMP9DHw==. (ca, ) |
| Aug 3, 2021 | 36 | assigning/reassigning Case (1) Docket Text: EXECUTIVE COMMITTEE ORDER: Case reassigned to the Honorable John Z. Lee for all further proceedings. Honorable Franklin U. Valderrama no longer assigned to the case. Signed by Executive Committee on 08/03/2021.(daj, ) |
| Jul 30, 2021 | 32 | attorney appearance (1) Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by Douglas E. McCann (McCann, Douglas) |
| Jul 30, 2021 | 33 | attorney appearance (1) Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by Martina T Hufnal (Hufnal, Martina) |
| Jul 30, 2021 | 34 | notice of filing (8) Docket Text: NOTICE by AbbVie Biotechnology Ltd, AbbVie Inc. - Notice of Filing Pursuant to Local Rule 40.4 (Berkowitz, Sean) |
| Jul 30, 2021 | 35 | set motion and R&R deadlines/hearings (1) Docket Text: MINUTE entry before the Honorable Franklin U. Valderrama: The Court sets the following briefing schedule on Defendant Alvotech HF.'S Rule 12(B)(1), 12(B)(2), 12(B)(6), and 12(B)(7) Motion to Dismiss for Lack of Subject Matter Jurisdiction, Lack of Personal Jurisdiction, Failure to State A Claim, and Failure to Join A Necessary Party [28]: Plaintiffs' response due on or before 08/20/2021. Defendant's reply due on or before 9/03/2021. The Court will rule on Defendant Alvotech HF.'S Rule 12(B)(1), 12(B)(2), 12(B)(6), and 12(B)(7) Motion to Dismiss for Lack of Subject Matter Jurisdiction, Lack of Personal Jurisdiction, Failure to State A Claim, and Failure to Join A Necessary Party [28] via CM/ECF. The joint initial status report remains due on 8/11/2021. Mailed notice (axc). |
| Jul 29, 2021 | 24 | attorney appearance (1) Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by Louis E Fogel (Fogel, Louis) |
| Jul 29, 2021 | 25 | motion to appear pro hac vice (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18512226. (Hufnal, Martina) |
| Jul 29, 2021 | 26 | motion to appear pro hac vice (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18512270. (McCann, Douglas) |
| Jul 29, 2021 | 27 | statement (3) Docket Text: RULE 7.1 CORPORATE DISCLOSURE STATEMENT by Alvotech hf. (Fogel, Louis) |
| Jul 29, 2021 | 28 | motion to dismiss (3) Docket Text: MOTION by Defendant Alvotech hf. to dismiss FOR LACK OF SUBJECT MATTER JURISDICTION, LACK OF PERSONAL JURISDICTION, FAILURE TO STATE A CLAIM, AND FAILURE TO JOIN A NECESSARY PARTY RULE 12(B)(1), 12(B)(2), 12(B)(6), AND 12(B)(7) (Fogel, Louis) |
| Jul 29, 2021 | 29 | memorandum in support of motion (21) Docket Text: MEMORANDUM by Alvotech hf. in support of motion to dismiss[28] (Fogel, Louis) |
| Jul 29, 2021 | 30 | declaration (Main Document) (3) Docket Text: DECLARATION of Louis E. Fogel regarding motion to dismiss[28] /In Support (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Fogel, Louis) |
| Jul 29, 2021 | 30 | declaration (Exhibit A) (3) Docket Text: DECLARATION of Louis E. Fogel regarding motion to dismiss[28] /In Support (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Fogel, Louis) |
| Jul 29, 2021 | 30 | declaration (Exhibit B) (2) Docket Text: DECLARATION of Louis E. Fogel regarding motion to dismiss[28] /In Support (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Fogel, Louis) |
| Jul 29, 2021 | 30 | declaration (Exhibit C) (2) Docket Text: DECLARATION of Louis E. Fogel regarding motion to dismiss[28] /In Support (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Fogel, Louis) |
| Jul 29, 2021 | 30 | declaration (Exhibit D) (4) Docket Text: DECLARATION of Louis E. Fogel regarding motion to dismiss[28] /In Support (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Fogel, Louis) |
| Jul 29, 2021 | 30 | declaration (Exhibit E) (6) Docket Text: DECLARATION of Louis E. Fogel regarding motion to dismiss[28] /In Support (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Fogel, Louis) |
| Jul 29, 2021 | 30 | declaration (Exhibit F) (2) Docket Text: DECLARATION of Louis E. Fogel regarding motion to dismiss[28] /In Support (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F)(Fogel, Louis) |
| Jul 29, 2021 | 31 | order on motion to appear pro hac vice (1) Docket Text: MINUTE entry before the Honorable Franklin U. Valderrama: Attorneys Martina Tyreus Hufnal [25] and Douglas E. McCann's [26] motions for leave to appear pro hac vice are granted. Mailed notice (axc). |
| Jul 28, 2021 | 23 | attorney appearance (1) Docket Text: ATTORNEY Appearance for Defendant Alvotech hf. by Jonathan Elliot Singer (Singer, Jonathan) |
| Jun 15, 2021 | 22 | attorney appearance (1) Docket Text: ATTORNEY Appearance for Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. by Brenda Lynn Danek (Danek, Brenda) |
| Jun 14, 2021 | 10 | motion to appear pro hac vice (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349254. (Frazier, David) |
| Jun 14, 2021 | 11 | motion to appear pro hac vice (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349305. (Chow, Arlene) |
| Jun 14, 2021 | 12 | motion to appear pro hac vice (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349340. (Yue, Herman) |
| Jun 14, 2021 | 13 | motion to appear pro hac vice (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349386. (Seringhaus, Michael) |
| Jun 14, 2021 | 14 | motion to appear pro hac vice (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349403. (Elliott, Tara) |
| Jun 14, 2021 | 15 | motion to appear pro hac vice (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349411. (LaHatte, Gabrielle) |
| Jun 14, 2021 | 16 | motion to appear pro hac vice (3) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349435. (Fry, Ashley) |
| Jun 14, 2021 | 17 | motion to appear pro hac vice (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349457. (Raich, William) |
| Jun 14, 2021 | 18 | motion to appear pro hac vice (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349472. (Collins-Chase, Charles) |
| Jun 14, 2021 | 19 | motion to appear pro hac vice (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349537. (Officer, Kassandra) |
| Jun 14, 2021 | 20 | motion to appear pro hac vice (2) Docket Text: MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number 0752-18349559. (Wang, Oulu) |
| Jun 14, 2021 | 21 | order on motion to appear pro hac vice (1) Docket Text: MINUTE entry before the Honorable Franklin U. Valderrama: Attorneys David P. Frazier [10], Arlene Lee Chow [11], Herman H. Yue [12]. Michael R. Seringhaus [13], Tara D. Elliott [14], Gabrielle LaHatte [15], Ashley M. Fry [16], William B. Raich [17], Charles T. Collins-Chase [18], Kassandra M. Officer [19] and Oulu Wang's [20] motions for leave to appear pro hac vice are granted. Mailed notice (axc). |
| Jun 10, 2021 | 9 | waiver of service executed (1) Docket Text: WAIVER OF SERVICE returned executed by AbbVie Inc., AbbVie Biotechnology Ltd. Alvotech hf. waiver sent on 5/28/2021, answer due 8/26/2021. (Berkowitz, Sean) |
| Jun 2, 2021 | 8 | set deadlines (1) Docket Text: MINUTE entry before the Honorable Franklin U. Valderrama: On or before 8/11/2021, the parties shall file a joint initial status report. A template for the Joint Initial Status Report, setting forth the information required, may be found at http://www.ilnd.uscourts.gov/Judges.aspx by clicking on Judge Valderrama's name and then again on the link entitled 'Joint Initial Status Report.' The court will enter a scheduling order in response. Plaintiff must serve this Minute Entry on all other parties. If the defendant(s) has not been served with process, plaintiff's counsel must contact the Courtroom Deputy at analeah_charles@ilnd.uscourts.gov to reschedule the Joint Initial Status Report deadline. Plaintiff should not file the Joint Initial Status Report before the defendant(s) has been served with process. The parties are further ordered to review all of Judge Valderrama's standing orders and the information available on his webpage. Mailed notice (axc). |
| May 28, 2021 | 1 | Complaint* (1) |
| May 28, 2021 | N/A | case assigned (0) Docket Text: CASE ASSIGNED to the Honorable Franklin U. Valderrama. Designated as Magistrate Judge the Honorable M. David Weisman. Case assignment: Random assignment. (mxo, ) |
| May 28, 2021 | 1 | complaint (Main Document) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Index of Exhibits) (4) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 1-16) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 17-22) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 23-30) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 31-37) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 38-42) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 43-49) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 50-55) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 56-59) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 60-62) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 63-65) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 1 | complaint (Exhibit 66-67) (30) Docket Text: COMPLAINT filed by AbbVie Inc., AbbVie Biotechnology Ltd; Filing fee $ 402, receipt number 0752-18299362. (Attachments: # (1) Index of Exhibits, # (2) Exhibit 1-16, # (3) Exhibit 17-22, # (4) Exhibit 23-30, # (5) Exhibit 31-37, # (6) Exhibit 38-42, # (7) Exhibit 43-49, # (8) Exhibit 50-55, # (9) Exhibit 56-59, # (10) Exhibit 60-62, # (11) Exhibit 63-65, # (12) Exhibit 66-67)(Berkowitz, Sean) |
| May 28, 2021 | 2 | attorney appearance (1) Docket Text: ATTORNEY Appearance for Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. by Sean M. Berkowitz (Berkowitz, Sean) |
| May 28, 2021 | 3 | attorney appearance (1) Docket Text: ATTORNEY Appearance for Plaintiffs AbbVie Biotechnology Ltd, AbbVie Inc. by Michael A. Morin (Morin, Michael) |
| May 28, 2021 | 4 | notification of affiliates pursuant to local rule 3.2 (3) Docket Text: NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by AbbVie Inc. (Berkowitz, Sean) |
| May 28, 2021 | 5 | notification of affiliates pursuant to local rule 3.2 (3) Docket Text: NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by AbbVie Biotechnology Ltd (Berkowitz, Sean) |
| May 28, 2021 | 6 | other (6) Docket Text: Local Rule 3.4 Notice of Claim Involving United States Patent by AbbVie Biotechnology Ltd, AbbVie Inc. (Berkowitz, Sean) |
| May 28, 2021 | 7 | civil cover sheet (2) Docket Text: CIVIL Cover Sheet (Berkowitz, Sean) |
